Patients with newly diagnosed multiple myeloma have different needs than pateints relapsed/refractory disease, and Beth Faiman addresses what some of these needs are.
Related Items
TOP - March 2022 Vol 15, No 2 published on March 16, 2022 in ASH
TOP - January 2020, Vol 13, No 1 published on January 10, 2020 in Hematologic Cancers
Web Exclusives published on November 5, 2019 in Financial Toxicity, Head and Neck Cancer, Hematologic Cancers, In the News, Leukemia
Last modified: July 22, 2021
